SCHEMBL834551

SCHEMBL834551

COc1ccc(CCc2ccc(OC)cc2)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.73
TUBB4A P04350 1/20 0.65
TUBB P07437 1/20 0.65
TUBA3C P0DPH7 1/20 0.65
TUBA1B P68363 1/20 0.65
TUBA4A P68366 1/20 0.65
TUBB4B P68371 1/20 0.65
TUBB3 Q13509 1/20 0.65
TUBB2A Q13885 1/20 0.65
TUBB8 Q3ZCM7 1/20 0.65
TUBA3E Q6PEY2 1/20 0.65
TUBA1A Q71U36 1/20 0.65
TUBA1C Q9BQE3 1/20 0.65
TUBB6 Q9BUF5 1/20 0.65
TUBB2B Q9BVA1 1/20 0.65
TUBB1 Q9H4B7 1/20 0.65
CA12 O43570 1/20 0.65
CA1 P00915 1/20 0.65
CA2 P00918 1/20 0.65
CA7 P43166 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10450398 0.92 TAAR1 (0.64) TAAR1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL2355634 0.90 LTA4H (0.75) TAAR1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL13038170 0.90 ACHE (0.71) TAAR1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL244070 0.89 CALM1 (0.79) TAAR1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL4254058 0.89 CALM1 (0.72) TAAR1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL15828875 0.88 TAAR1 (0.59) TAAR1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL9468301 0.88 TAAR1 (0.95) TAAR1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL1991025 0.88 MEN1 (0.61) TAAR1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL5253951 0.88 TAAR1 (0.59) TAAR1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL7474018 0.88 KDM4E (0.60) TAAR1TUBB4ATUBBTUBA3CTUBA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118666692-A Method for preparing aromatic diamine from anisyl alcohol 中国科学院大连化学物理研究所 2024-09-20 CN claimed
US-4087463-A COBALT CARBONYL CATALYST MONSANTO COMPANY (US) 1978-05-02 US claimed
US-20250326771-A1 PIPERAZINE DERIVATIVES USEFUL IN HIV THERAPY VIIV HEALTHCARE CO (US) 2025-10-23 US disclosed
CN-119487019-A Piperazine derivatives for HIV therapy VIIV保健公司 2025-02-18 CN disclosed
CN-118666692-A Method for preparing aromatic diamine from anisyl alcohol 中国科学院大连化学物理研究所 2024-09-20 CN disclosed
WO-2023230541-A1 PIPERAZINE DERIVATIVES USEFUL IN HIV THERAPY VIIV HEALTHCARE COMPANY (US) 2023-11-30 WO disclosed
WO-2023230541-A1 PIPERAZINE DERIVATIVES USEFUL IN HIV THERAPY VIIV HEALTHCARE COMPANY (US) 2023-11-30 WO disclosed
EP-3313828-B1 METALLO-BETA-LACTAMASE INHIBITORS MERCK SHARP & DOHME LLC (US) 2023-07-12 EP disclosed
EP-3458510-B2 POLYCARBONATE COMPOSITIONS CONTAINING A CARBOXYLIC ACID AND THEIR OR GLYCEROL OR DIGLYCEROL ESTERS COVESTRO DEUTSCHLAND AG (DE) 2023-05-24 EP disclosed
US-20230120881-A1 BINUCLEAR GOLD(I) COMPOUNDS FOR PHOTOCATALYSIS APPLICATIONS University of Hong Kong Versitech Limited (CN) 2023-04-20 US disclosed
US-20230120881-A1 BINUCLEAR GOLD(I) COMPOUNDS FOR PHOTOCATALYSIS APPLICATIONS University of Hong Kong Versitech Limited (CN) 2023-04-20 US disclosed
US-20070219301-A1 Liquid-Crystal Polyester Resin Composition SUMITOMO CHEMICAL CO., LTD. (JP) 2007-09-20 US disclosed
US-20070173565-A1 Wholly aromatic liquid crystal polyester resin composition and optical pickup lens holder ENEOS MATERIALS CORPORATION (JP) 2007-07-26 US disclosed
WO-2003082786-A1 A PROCESS FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE ALPHA-ASARONE FROM TOXIC BETA-ASARONE RICH ACORUS CALAMUS OIL COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2003-10-09 WO disclosed
US-6590127-B1 Formation of alpha-asarone, isoacoramone and 2,4,5-trimethoxycinnamaldehyde in one step process via 2,3-dichloro-5,6-dicyano-1,4-benzoquinone assisted dehydrogenation/oxidation of 2,4,5-trimethoxyphenylpropane COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2003-07-08 US disclosed
EP-0491560-B1 Method for producing liquid discharging recording head CANON KK (JP) 1997-10-01 EP disclosed
US-5331344-A Method for producing liquid-discharging recording head, liquid-discharging recording head produced by said method, and recording apparatus utilizing said recording head CANON KABUSHIKI KAISHA (JP) 1994-07-19 US disclosed
EP-0491560-A2 Liquid discharging recording head and method for producing same CANON KABUSHIKI KAISHA (JP) 1992-06-24 EP disclosed
US-4552876-A ANTIALLERGENS, ANTIINFLAMMATORY AGENTS USV PHARMACEUTICAL CORP. (US) 1985-11-12 US disclosed
US-4087463-A COBALT CARBONYL CATALYST MONSANTO COMPANY (US) 1978-05-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250326771-A1 PIPERAZINE DERIVATIVES USEFUL IN HIV THERAPY CCR5, THPO, IL5 TAAR1 4064/4885TUBB4A 662/4885TUBB 349/4885
US-20230120881-A1 BINUCLEAR GOLD(I) COMPOUNDS FOR PHOTOCATALYSIS APPLICATIONS PPOX, AP3M1, AP2M1 TAAR1 2478/4885TUBB4A 2679/4885TUBB 2586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.